doi: 10.5732/cjc.012.10277

Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance

Ana R. Gomes, Fung Zhao, Eric W.F. Lam

Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, W12 0NN, United Kingdom.

[Abstract] The FOXO3a and FOXM1 forkhead transcription factors are key players in cancer initiation, progression, and drug resistance. Recent research shows that FOXM1 is a direct transcriptional target of FOXO3a, a vital downstream effector of the PI3K-AKT-FOXO signaling cascade. In addition, FOXM1 and FOXO3a also antagonize each other’s activity by competitively binding to the same target genes, which are involved in chemotherapeutic drug sensitivity and resistance. Understanding the role and regulation of the FOXO-FOXM1 axis will provide insight into chemotherapeutic drug action and resistance in patients, and help to identify novel therapeutic approaches as well as diagnostic and predictive biomarkers.

Chinese Journal of Cancer 2013, Volume: 32, Issue 7, Page: 365-370

[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]

Cite this article

Ana R. Gomes, Fung Zhao, Eric W.F. Lam. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance. Chin J Cancer. 2013, 32(7):365-370. doi:10.5732/cjc.012.10277


Export citations

EndNote